Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed BSE that its Board of Directors will meet on 29 July 2025. The agenda includes considering and approving the Unaudited Financial Results for the period under review. No specific financial numbers, dividend announcements, or other agenda items have been disclosed in this intimation. This is a standard regulatory filing ahead of the company's quarterly results declaration.
This is a routine intimation with no immediate impact on shareholders. Investors should watch for the actual results announcement on or after 29 July 2025 for any material figures or decisions.